Significant reduction of oncologic pulmonary death by local control for pulmonary oligometastases treated with stereotactic body radiotherapy

Takaya Yamamoto, Yuzuru Niibe, Kazunari Yamada, Masahiko Aoki, Hiroshi Onishi, Kuniaki Katsui, Yasuhiro Dekura, Atsushi Nishikawa, Yoshihiko Manabe, Hideomi Yamashita, Keiichi Jingu

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)


Background and purpose: The rate of oncologic pulmonary death after stereotactic body radiotherapy for pulmonary oligometastases has never been reported. The purpose of current study was to investigate the rate of freedom from oncologic pulmonary death (FOPD) and to analyze factors affecting for FOPD. Materials and methods: The inclusion criteria for this retrospective study were that SBRT was performed between 2004 and 2015, the number of metastases was 5 or less, the primary lesion and extrathoracic metastases needed to be controlled before SBRT and a biological effective dose (BED10) of 75 Gy or more was needed. The Kaplan–Meier estimator and the log-rank test were used to calculate and compare the stratified rates of FOPD. The Cox proportional hazards model was used for multivariate analyses (MVA). Primary disease death from a non-oncologic pulmonary cause was censored in model 1 and was excluded in model 2. Results: A total of 1172 patients with 1315 tumors were enrolled. During a median follow-up period of 24.5 months, oncologic pulmonary deaths accounted for 101 of 221 primary disease deaths. The 1-year, 3-year and 5-year FOPD rates in model 1 were 98.2%, 89.4% and 84.0%, respectively. MVA for FOPD revealed that local failure of the irradiated tumor, squamous cell carcinoma pathology, and chemotherapy after SBRT had significant relationships with lower FOPD rates in both model 1 and model 2. Conclusions: Successful local control of pulmonary oligometastases by SBRT contributed to a higher FOPD rate.

Original languageEnglish
Pages (from-to)86-91
Number of pages6
JournalRadiotherapy and Oncology
Publication statusPublished - Jun 2020


  • Oncologic pulmonary death
  • Pulmonary oligometastases
  • Stereotactic body radiotherapy (SBRT)

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Radiology Nuclear Medicine and imaging


Dive into the research topics of 'Significant reduction of oncologic pulmonary death by local control for pulmonary oligometastases treated with stereotactic body radiotherapy'. Together they form a unique fingerprint.

Cite this